Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1993 Jun;77(6):364–365. doi: 10.1136/bjo.77.6.364

Reduction in mydriatic drop size in premature infants.

S Wheatcroft 1, A Sharma 1, J McAllister 1
PMCID: PMC504531  PMID: 8318484

Abstract

In a prospective study of 26 premature infants, 5 microliters microdrops were compared with standard 26 microliters eye drops of cyclopentolate 0.5% and phenylephrine 2.5%. There was no statistical difference in pupil dilatation. The 5 microliters microdrops have potentially fewer adverse effects in premature infants.

Full text

PDF
364

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauer C. R., Trottier M. C., Stern L. Systemic cyclopentolate (Cyclogyl) toxicity in the newborn infant. J Pediatr. 1973 Mar;82(3):501–505. doi: 10.1016/s0022-3476(73)80134-9. [DOI] [PubMed] [Google Scholar]
  2. Brown R. H., Hotchkiss M. L., Davis E. B. Creating smaller eyedrops by reducing eyedropper tip dimensions. Am J Ophthalmol. 1985 Apr 15;99(4):460–464. doi: 10.1016/0002-9394(85)90013-3. [DOI] [PubMed] [Google Scholar]
  3. Carpel E. F., Kalina R. E. Pupillary responses to mydriatic agents in premature infants. Am J Ophthalmol. 1973 Jun;75(6):988–991. doi: 10.1016/0002-9394(73)91086-6. [DOI] [PubMed] [Google Scholar]
  4. Gray R. H. The influence of drop size on pupil dilatation. Eye (Lond) 1991;5(Pt 5):615–619. doi: 10.1038/eye.1991.107. [DOI] [PubMed] [Google Scholar]
  5. Hermansen M. C., Sullivan L. S. Feeding intolerance following ophthalmologic examination. Am J Dis Child. 1985 Apr;139(4):367–368. doi: 10.1001/archpedi.1985.02140060049026. [DOI] [PubMed] [Google Scholar]
  6. Lees B. J., Cabal L. A. Increased blood pressure following pupillary dilation with 2.5% phenylephrine hydrochloride in preterm infants. Pediatrics. 1981 Aug;68(2):231–234. [PubMed] [Google Scholar]
  7. Lynch M. G., Brown R. H., Goode S. M., Schoenwald R. D., Chien D. S. Reduction of phenylephrine drop size in infants achieves equal dilation with decreased systemic absorption. Arch Ophthalmol. 1987 Oct;105(10):1364–1365. doi: 10.1001/archopht.1987.01060100066027. [DOI] [PubMed] [Google Scholar]
  8. Palmer E. A. How safe are ocular drugs in pediatrics? Ophthalmology. 1986 Aug;93(8):1038–1040. doi: 10.1016/s0161-6420(86)33624-8. [DOI] [PubMed] [Google Scholar]
  9. Rengstorff R. H., Doughty C. B. Mydriatic and cycloplegic drugs: a review of ocular and systemic complications. Am J Optom Physiol Opt. 1982 Feb;59(2):162–177. [PubMed] [Google Scholar]
  10. Rosales T., Isenberg S., Leake R., Everett S. Systemic effects of mydriatics in low weight infants. J Pediatr Ophthalmol Strabismus. 1981 Nov-Dec;18(6):42–44. doi: 10.3928/0191-3913-19811101-11. [DOI] [PubMed] [Google Scholar]
  11. Shell J. W. Pharmacokinetics of topically applied ophthalmic drugs. Surv Ophthalmol. 1982 Jan-Feb;26(4):207–218. doi: 10.1016/0039-6257(82)90081-9. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES